CoChat
Sign Up
Cited by 59

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder.

Oravecz-Wilson, Katherine I., Philips, Steven T., Yilmaz, Ömer H., Ames, Heather M., Li, Lina, Crawford, Brendan D., Gauvin, Alice M., Lucas, Peter C., Sitwala, Kajal, Downing, James R., Morrison, Sean J., Ross, Theodora S.·2009·Cancer Cell
DOI 10.1016/j.ccr.2009.06.007PMC PMC2763369
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2009.06.007

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 30

  1. Breuer, 1991, Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras, Cancer Res., 51, 958
  2. Cano, 2008, Leukaemia lineage specification caused by cell-specific Mll-Enl translocations, Oncogene, 27, 1945, 10.1038/sj.onc.1210818 · DOI
  3. Chen, 2008, Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells, Cancer Cell, 13, 432, 10.1016/j.ccr.2008.03.005 · DOI
  4. Curtis, 2007, A novel ETV6-PDGFRB fusion transcript missed by standard screening in a patient with an imatinib responsive chronic myeloproliferative disease, Leukemia, 21, 1839, 10.1038/sj.leu.2404728 · DOI
  5. Druker, 2006, Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia, N. Engl. J. Med., 355, 2408, 10.1056/NEJMoa062867 · DOI
  6. Gilliland, 2002, Molecular genetics of human leukemias: new insights into therapy, Semin. Hematol., 39, 6, 10.1053/shem.2002.36921 · DOI
  7. Golub, 1994, Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation, Cell, 77, 307, 10.1016/0092-8674(94)90322-0 · DOI
  8. Grand, 2004, p53-Binding protein 1 is fused to the platelet-derived growth factor receptor beta in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder, Cancer Res., 64, 7216, 10.1158/0008-5472.CAN-04-2005 · DOI
  9. Grisolano, 2003, An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice, Proc. Natl. Acad. Sci. USA, 100, 9506, 10.1073/pnas.1531730100 · DOI
  10. Higuchi, 2002, Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia, Cancer Cell, 1, 63, 10.1016/S1535-6108(02)00016-8 · DOI
  11. Huettner, 2000, Reversibility of acute B-cell leukaemia induced by BCR-ABL1, Nat. Genet., 24, 57, 10.1038/71691 · DOI
  12. Jaiswal, 2003, Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias, Proc. Natl. Acad. Sci. USA, 100, 10002, 10.1073/pnas.1633833100 · DOI
  13. Jorgensen, 2006, Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate, Clin. Cancer Res., 12, 626, 10.1158/1078-0432.CCR-05-0429 · DOI
  14. Kavalerchik, 2008, Chronic myeloid leukemia stem cells, J. Clin. Oncol., 26, 2911, 10.1200/JCO.2008.17.5745 · DOI
  15. Kogan, 2002, Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice, Blood, 100, 238, 10.1182/blood.V100.1.238 · DOI · Paper page
  16. Kuhn, 1995, Inducible gene targeting in mice, Science, 269, 1427, 10.1126/science.7660125 · DOI · Paper page
  17. Lee, 2007, FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia, Cancer Cell, 12, 367, 10.1016/j.ccr.2007.08.031 · DOI
  18. Li, 2008, Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model, Blood, 111, 3849, 10.1182/blood-2007-08-109942 · DOI
  19. Neering, 2007, Leukemia stem cells in a genetically defined murine model of blast-crisis CML, Blood, 110, 2578, 10.1182/blood-2007-02-073031 · DOI · Paper page
  20. Oravecz-Wilson, 2004, Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts, Hum. Mol. Genet., 13, 851, 10.1093/hmg/ddh102 · DOI
  21. Reilly, 2003, Receptor tyrosine kinases in normal and malignant haematopoiesis, Blood Rev., 17, 241, 10.1016/S0268-960X(03)00024-9 · DOI
  22. Ross, 1998, Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2), Blood, 91, 4419, 10.1182/blood.V91.12.4419 · DOI
  23. Ross, 1999, Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein, J. Biol. Chem., 274, 22328, 10.1074/jbc.274.32.22328 · DOI
  24. Savona, 2008, Getting to the stem of chronic myeloid leukaemia, Nat. Rev. Cancer, 8, 341, 10.1038/nrc2368 · DOI
  25. Sawyers, 1992, Propagation of human blastic myeloid leukemias in the SCID mouse, Blood, 79, 2089, 10.1182/blood.V79.8.2089.2089 · DOI
  26. Schessl, 2005, The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice, J. Clin. Invest., 115, 2159, 10.1172/JCI24225 · DOI
  27. Sirard, 1996, Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis, Blood, 87, 1539, 10.1182/blood.V87.4.1539.bloodjournal8741539 · DOI
  28. Tefferi, 2007, Oncogenes in myeloproliferative disorders, Cell Cycle, 6, 550, 10.4161/cc.6.5.3919 · DOI
  29. Wolff, 2001, Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571, Blood, 98, 2808, 10.1182/blood.V98.9.2808 · DOI
  30. Yilmaz, 2006, Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells, Nature, 441, 475, 10.1038/nature04703 · DOI · Paper page

Cited by

Metadata

Authors
Oravecz-Wilson, K. I., Philips, S. T., Yilmaz, Ö. H., Ames, H. M., Li, L., Crawford, B. D., Gauvin, A. M., Lucas, P. C., Sitwala, K., Downing, J. R., Morrison, S. J., & Ross, T. S.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2009-08
Volume
16
Issue
2
Pages
137-148
ISSN
1535-6108
DOI
10.1016/j.ccr.2009.06.007
PMC
PMC2763369
Cited by
59
References
2
Language
en
Licence
Funders
  • Burroughs Wellcome Fund
  • Howard Hughes Medical Institute
  • National Cancer Institute (CBTG CA009676, R01 CA098730-01, R01 CA82363-03)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review